PharmiWeb.com - Global Pharma News & Resources
24-Sep-2021

Virginiamycin Market Focus on Adopting Different Strategies to Enhance Their Market Share

Virginiamycin belongs to the family of glycopeptide antibiotics. These antibiotics are synthesized from peptides derived from marine or acriflavine. This antibiotic has antifungal properties that are very useful in treating fungal infections including yeast. It also kills bacteria by producing hydrogen peroxide. The antibiotic acts by killing the bacteria responsible for chronic sinusitis and thrush. One of the key factors aiding growth of the market is key pharmaceutical companies are focused on new product launches. As a matter of fact, these companies are laying emphasis on research and development activities, in order to gain a competitive advantage in the market. Recently, in January 2019, Phibro Animal Health Corp. received the Veterinary Drugs Directorate (VDD), Health Canada approval for its virginiamycin medicated feed additive for use in beef cattle. Thus, such factors can stimulate growth of the market.

Request Sample Copy of Virginiamycin Report @
https://www.coherentmarketinsights.com/insight/request-sample/2621

Virginiamycin belongs to the sulfonyl group of antibiotics like streptogramin, amikacin, chloramphenicol, streptomycin, and gentamycin. It is an efficient combination of streptogramin and virginiamycin. Virginiamycin has been used in the fuel industry to avoid microbial contamination. It also has germicide, antimicrobial and anti-inflammatory properties. One of the key applications of Virginiamycin is that it can be used as a growth stimulator. Since it optimizes the absorption and metabolism of nutrients, virginiamycin has witnessed significant demand in the recent past. Besides, it improves the state of the small intestine epithelium and limits growth of harmful toxins. Hence, such advantages can augment growth of the virginiamycin market in the near future.

The use of virginiamycin in the food industry has been found to be effective in controlling pathogenic microorganisms such as yeast and fungi in both poultry and swine. The benefits include an increased tolerance to antibiotics, a lower level of mortality in sick cattle, improved feed efficiency in livestock, and production of higher quality eggs. As far as regional impact is concerned, North America seems to be gaining significant traction in the virginiamycin market. This is typically due to the significant emphasis on animal nutrition across developed economies such as the U.S. and Canada. Furthermore, Europe is likely to register a positive outlook due to growing investment in animal healthcare.

It has been found that virginiamycin helps in improving feed efficiency and promotes growth of leaner broiler chickens. It prevents the occurrence of excessive feed loss in broilers and improves the growth rate of chicks in laying hens. The feeding rate of laying hens is increased when antibiotics are administered to them after they have been infected with pathogenic microorganisms. Regardless of these benefitting factors, there are certain aspects of the market that could limit its future adoption. For instance, there are stringent regulations on the use of virginiamycin, which could impede growth of the virginiamycin market.

Request PDF Report Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2621

Table Of Content

Chapter No. 1 Introduction

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. USP & Key Offerings

1.2. Key Benefits for Stakehulders

1.3. Target Audience

1.4. Report Scope

Chapter No. 2 Executive Summary

2.1. Key Findings

2.1.1. Top Investment Pockets

2.1.1.1. Market Attractiveness Analysis, By Type

2.1.1.2. Market Attractiveness Analysis, By End Use

2.1.1.3. Market Attractiveness Analysis, By Region

2.2. Market Snapshot

2.3. Global Virginiamycin Market, 2016 – 2021 (USD Million)

2.4. Insights from Primary Respondents

Chapter No. 3 COVID 19 Impact Analysis

3.1. Impact Assessment of COVID-19 Pandemic, By Region

3.1.1. North America

3.1.2. Europe

3.1.3. Asia Pacific

3.1.4. Latin America

3.1.5. The Middle-East and Africa

Customization of the Report

In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Also, Research Report Examines:

• Competitive companies and manufacturers in global market

• By Product Type, Applications & Growth Factors

• Industry Status and Outlook for Major Applications / End Users / Usage Area

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 25-Sep-2021